BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Doximity Appoints Teladoc Health CEO Jason Gorevic to Board of Directors

  Healthcare Business Leader to Advise Doximity on Growth and Market Strategies

  April 3, 2019

   · 

  2 min read
• Business

  Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing

  Ajinomoto Bio-Pharma Services, a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Jean-Baptiste Agnus has joined Aji Bio-Pharma as Vice President of Sales and Marketing.

  April 3, 2019

   · 

  2 min read
• Genetown

  Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases

  FORCE™ platform of antibody conjugates will deliver nucleic acids and other molecules for the treatment of serious muscle diseases

  April 3, 2019

   · 

  6 min read
• Business

  Avanos Medical Announces FDA Clearance for ON-Q* with Bolus

  Avanos Medical, Inc. (NYSE: AVNS), a company focused on delivering clinically superior medical device solutions to improve patients’ quality of life, announced today that it has received U.S. Food and Drug Administration (FDA) 501(k) clearance for its ON-Q* with Bolus pump.

  April 3, 2019

   · 

  5 min read
• Drug Development

  Compugen Presents Update on COM701 Phase 1 Trial at the 2019 AACR Annual Meeting

  Compugen Ltd. announced that its ongoing Phase 1 clinical trial evaluating COM701, a first-in-class therapeutic antibody targeting PVRIG, was featured in a trial-in-progress poster at The 2019 AACR Annual Meeting in Atlanta, GA.

  April 3, 2019

   · 

  4 min read
• Alkermes Expands Awards Program With Focus on Advancing Research in Schizophrenia

  The Second Annual ALKERMES PATHWAYS RESEARCH AWARDS (SM) Program Will Provide Funding for Up To Eight Research Projects With Individual Grant Amounts of Up To $100,000 per Project

  April 3, 2019

   · 

  4 min read
• Genetown

  Enzyvant’s Investigational Regenerative Treatment (RVT-802) for Congenital Athymia to be Discussed in Symposium, Platform Presentation and Poster Session at Clinical Immunology Society Meeting

  Enzyvant announced that its investigational regenerative treatment in late-stage development for congenital athymia will be featured during a platform presentation, at a symposium, and in a poster session at the Clinical Immunology Society 2019 annual meeting in Atlanta, GA, April 4-7.

  April 3, 2019

   · 

  4 min read
• BioForest

  CTI BioPharma to Present at the 18th Annual Needham Healthcare Conference on Wednesday, Apr. 10

  CTI BioPharma Corp. announced that management will provide a corporate overview at the 18th Annual Needham Healthcare Conference at 9:20 a.m. EDT at the Westin New York Grand Central.

  April 3, 2019

   · 

  1 min read
• Biotech Beach

  Barco® Uniforms Debuts Grey’s Anatomy™ EDGE Line

  Sophisticated Line Features Nylex™ ‘Super Fabric’ for Functional, Modern Aesthetic

  April 3, 2019

   · 

  3 min read
• Business

  Intrexon Intensifies Focus on Healthcare, Forms Two Units and Streamlines Management

  Two therapeutic candidates from Precigen’s game-changing UltraCAR-T™ therapeutic platform commencing clinical studies

  April 3, 2019

   · 

  5 min read